Coralie P.
- Country
- France
- Department
- nephrology
Research Overview
- Efficacy of Prophylactic Rituximab in Preventing EBV Infection and PTLD in EBV-Negative Kidney Transplant Recipients
- INduction in Sensitized kidney Transplant recipients without pre-Existing donor-specific AntiboDies: a randomized multicentre trial between a lymphocyte depleting and basiliximab (INSTEAD)
Data & Insights
Has run more than one trial at 11 of 26 partner sites.
Specializations
Transplant Medicine
This investigator specializes in kidney transplantation, with particular emphasis on managing complications and optimizing outcomes for transplant recipients.
- Transplant Immunology
- Immunosuppression Protocols
- Graft Rejection Prevention
The research focuses on developing effective prevention strategies for transplant recipients and improving long-term outcomes.
Viral Complications
Expertise in managing Epstein-Barr virus (EBV) infections in transplant patients, with specific attention to prevention strategies in high-risk populations.
- Post-transplant Viral Infections
- EBV Prevention Protocols
- Lymphoproliferative Disorders
The investigator studies prophylactic approaches to prevent viral complications in transplant recipients.
Immunological Research
Specialized focus on transplant immunology and the development of targeted immunosuppressive strategies for sensitized kidney transplant recipients.
- Antibody-Mediated Rejection
- Immunosuppressive Protocols
- Donor-Specific Antibodies
Research encompasses innovative approaches to prevent rejection in high-risk transplant populations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.